Six patents currently held, every record listed here
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Nov 2030. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
1
Ending by 2030
Nov 2030
Next term end
5
Patent families
When these terms end
Each bar runs from grant to computed term end. 2015 to 2038.20202025203020352038
Every computed term in this portfolio is shown above.Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends May 2034 · High confidence
Also notable
Ends Mar 2036 · High confidence
Also notable
Ends Nov 2030 · High confidence
Medium for Yeasts
US 10,023,836
Granted 2018 and renewed at every maintenance window due so far. Protection runs to 2034.
Composition for Improving or Preventing Nonalcoholic Fatty Liver
US 11,207,371
A family of 5 related applications built on the 2021 grant. Protection runs to 2036.
Yeast Mutant and Yeast Extract
US 9,084,435
Granted 2015 and renewed at every maintenance window due so far. Protection runs to 2030.
Formerly held, still cited
Notable
Ends Jun 2033 · High confidence
The most cited patent in this portfolio, cited by 6 later US patents, top 25% of utility patents granted in 2021 in our data. Protection runs to 2033.
now held by Mitsubishi Corporation Life Sciences Limited
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jan 21, 2027The maintenance fee for Yeast Mutant and Yeast Extract (US 9,084,435) comes due Jan 21, 2027. Unpaid by Jul 21, 2027, it lapses early.
- 1 fee due Apr 3, 2027The maintenance fee for Composition for Improving or Preventing Nonalcoholic Fatty Liver (US 11,771,735) comes due Apr 3, 2027. Unpaid by Oct 4, 2027, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
What they patent
Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.
| Composition for Improving or Preventing Nonalcoholic Fatty Liver | 2 in force | to Mar 2036 |
| Salty Taste Enhancing Composition | 1 in force | to Jan 2038 |
| Medium for Yeasts | 1 in force | to May 2034 |
| Effective Use of Yeast and Yeast Extract Residue | 1 in force | to Apr 2033 |
| Yeast Mutant and Yeast Extract | 1 in force | to Nov 2030 |
Patents held now
Soonest term end first.
Showing 1 to 6 of 6
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,084,435 | Yeast Mutant and Yeast Extract In force · High confidence | In force | High confidence | |
| US 10,196,430 | Effective Use of Yeast and Yeast Extract Residue In force · High confidence | In force | High confidence | |
| US 10,023,836 | Medium for Yeasts held by Yamaguchi University and Kohjin Life Sciences Co., Ltd. In force · High confidence | In force | High confidence | |
| US 11,207,371 | Composition for Improving or Preventing Nonalcoholic Fatty Liver In force · High confidence | In force | High confidence | |
| US 11,771,735 | Composition for Improving or Preventing Nonalcoholic Fatty Liver In force · High confidence | In force | High confidence | |
| US 11,058,136 | Salty Taste Enhancing Composition In force · High confidence | In force | High confidence |
Also on record, not counted in the 6: 1 patent in force now held by others · 4 patents ended · 14 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.